Antithyroid drugs is the main choice for the TT‐12 young (19–22 years old) female patient, as it is in most countries/regions, 4 , 5 , 6 , 24 , 25 but an interesting trend in these patients is that surgery has gained popularity in some of these cases, for example, Europe and the USA show a 20–30% operation preference of patients in this age group. 8 , 9 The change over time could be attributed to the difference in the variations of the index cases introduced over time.
← all excerpts
Treatment of patients with Graves' disease in Sweden compared to international surveys of an 'index patient'.
1
—
—